Neuromodulatory potential of phenylpropanoids; para-methoxycinnamic acid and ethyl-p-methoxycinnamate on aluminum-induced memory deficit in rats

References

• Abdel-Aal RA, Assi AA, Kostandy BB. 2011a. Memantine prevents aluminum-induced cognitive deficit in rats. Behav Brain Res. 225:31–38.
   PubMed Web of Science ®Google Scholar
• Abdel-Aal RA, Assi AA, Kostandy BB. 2011b. Rivastigmine reverses aluminum-induced behavioral changes in rats. Eur J Pharmacol. 659:169–176.
   PubMed Web of Science ®Google Scholar
• Aebi, H. 1974. Catalase. In: Hans Ulrich Bergmeyer, editor. Methods of Enzymatic Analysis. 2nd ed. New York (NY) and London: Academic Press; p. 637–684.
   Google Scholar
• Bennett S, Grant MM, Aldred S. 2009. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. J Alzheimers Dis. 17:245–257.
   PubMed Web of Science ®Google Scholar
• Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. 2000. The Protein Data Bank. Nucleic Acids Res. 28:235–242.
   Google Scholar
• Bielarczyk H, Tomaszewicz M, Szutowicz A. 1998. Effect of Aluminum on acetyl-CoA and acetylcholine metabolism in nerve terminals . J Neurochem. 70:1175–1181.
   PubMed Web of Science ®Google Scholar
• Blaylock R L. 2012. Aluminum induced immunoexcitotoxicity in neurodevelopmental and neurodegenerative disorders. Curr Inorg Chem. 2:46–53.
   Google Scholar
• Butterfield DA, Reed T, Newman SF, Sultana R. 2007. Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med. 43:658–677.
   PubMed Web of Science ®Google Scholar
• Campbell A. 2002. The potential role of aluminium in Alzheimer's disease. Nephrol Dial Transplant. 17:17.
   PubMed Web of Science ®Google Scholar
• Crichton RR, Wilmet S, Legssyer R, Ward RJ. 2002. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem. 91:9–18.
   PubMed Web of Science ®Google Scholar
• Drago D, Cavaliere A, Mascetra N, Ciavardelli D, Di Ilio C, Zatta P, Sensi SL. 2008. Aluminum modulates effects of β Amyloid1–42 on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease. Rejuvenation Res. 11:861–871.
   PubMed Web of Science ®Google Scholar
• Duthey B. 2013. Background paper 6.11: Alzheimer disease and other dementias. A Public Health Approach to Innovation. p. 1–74.
   Google Scholar
• Edwardson JA, Candy JM, Ince PG, McArthur FK, Morris CM, Oakley AE, Taylor GA, Bjertness E. 1992. Aluminium accumulation, amyloid deposition and neurofibrillary changes in the central nervous system. Ciba Found Symp. 169: 165–179.
   PubMedGoogle Scholar
• Ellman GL, Courtney KD, Andres V, Jr, Featherstone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7:88–95.
   PubMed Web of Science ®Google Scholar
• El-Rahman SS. 2003. Neuropathology of aluminum toxicity in rats (glutamate and GABA impairment). Pharmacol Res. 47:189–194.
   PubMed Web of Science ®Google Scholar
• Fernandes J, Mudgal J, Rao CM, Arora D, Basu Mallik S, Pai KS, Nampoothiri M. 2018. N-acetyl-L-tryptophan, a substance-P receptor antagonist attenuates aluminum-induced spatial memory deficit in rats. Toxicol Mech Methods. 28:328–334.
   PubMed Web of Science ®Google Scholar
• Flaten TP. 2001. Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Res Bull. 55:187–196.
   PubMed Web of Science ®Google Scholar
• Francis PT, Palmer AM, Snape M, Wilcock GK. 1999. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry. 66:137–147.
   PubMed Web of Science ®Google Scholar
• Glowinski J, Iversen LL. 1966. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem. 13:655–669.
   PubMed Web of Science ®Google Scholar
• Gustafson L. 1996. What is dementia?. Acta Neurol Scand. 94:22–24.
   Web of Science ®Google Scholar
• Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. 2004. Redox‐active metals, oxidative stress, and Alzheimer's disease pathology. Ann NY Acad Sci. 1012:153–163.
   PubMed Web of Science ®Google Scholar
• Huang WJ, Zhang XI, Chen WW. 2016. Role of oxidative stress in Alzheimer's disease. Biomed Rep. 4:519–522.
   PubMed Web of Science ®Google Scholar
• Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG. 2012. ZINC: a free tool to discover chemistry for biology. J Chem Inf Model. 52:1757–1768.
   PubMed Web of Science ®Google Scholar
• Ittner LM, Götz J. 2011. Amyloid-β and tau – a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci. 12:67.
   Web of Science ®Google Scholar
• John J, Nampoothiri M, Kumar N, Mudgal J, Nampurath GK, Chamallamudi MR. 2015. Sesamol, a lipid lowering agent, ameliorates aluminium chloride induced behavioral and biochemical alterations in rats. Pharmacogn Mag. 11:327.
   PubMed Web of Science ®Google Scholar
• Kaizer RR, Gutierres JM, Schmatz R, Spanevello RM, Morsch VM, Schetinger MR, Rocha JB. 2010. In vitro and in vivo interactions of aluminum on NTPDase and AChE activities in lymphocytes of rats. Cell Immunol. 265:133–138.
   PubMed Web of Science ®Google Scholar
• Kandiah N, Pai MC, Senanarong V, Looi I, Ampil E, Park KW, Karanam AK, Christopher S. 2017. Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia. Clin Interv Aging. 12:697.
   PubMed Web of Science ®Google Scholar
• Kawahara M, Kato-Negishi M. 2011. Link between aluminum and the pathogenesis of Alzheimer’s disease: the integration of the aluminum and amyloid cascade hypotheses. Int J Alzheimers Dis. 2011:Article ID 276393,17 pages.
   Google Scholar
• Khan KA, Kumar N, Nayak PG, Nampoothiri M, Shenoy RR, Krishnadas N, Rao CM, Mudgal J. 2013. Impact of caffeic acid on aluminium chloride-induced dementia in rats. J Pharm Pharmacol. 65:1745–1752.
   PubMed Web of Science ®Google Scholar
• Kim SR, Kang SY, Lee KY, Kim SH, Markelonis GJ, Oh TH, Kim YC. 2003. Anti-amnestic activity of E-p-methoxycinnamic acid from Scrophularia buergeriana. Brain Res Cogn Brain Res. 17:454–461.
   PubMedGoogle Scholar
• Kim SR, Kim YC. 2000. Neuroprotective phenylpropanoid esters of rhamnose isolated from roots of Scrophularia buergeriana. Phytochemistry. 54:503–509.
   PubMed Web of Science ®Google Scholar
• Kim SR, Sung SH, Jang YP, Markelonis GJ, Oh TH, Kim YC. 2002. E-p-methoxycinnamic acid protects cultured neuronal cells against neurotoxicity induced by glutamate. Br J Pharmacol. 135:1281–1291.
   PubMed Web of Science ®Google Scholar
• Kumar S. 1999. Aluminium-induced biphasic effect. Med Hypotheses. 52:557–559.
   PubMed Web of Science ®Google Scholar
• Kumar A, Dogra S, Prakash A. 2009. Protective effect of curcumin (Curcuma longa), against aluminium toxicity: possible behavioral and biochemical alterations in rats. Behav Brain Res. 205:384–390.
   PubMed Web of Science ®Google Scholar
• Kumar V, Gill KD. 2009. Aluminium neurotoxicity: neurobehavioural and oxidative aspects. Arch Toxicol. 83:965–978.
   PubMed Web of Science ®Google Scholar
• Mallik SB, Mudgal J, Nampoothiri M, Hall S, Anoopkumar-Dukie S, Grant G, Rao CM, Arora D. 2016. Caffeic acid attenuates lipopolysaccharide-induced sickness behaviour and neuroinflammation in mice. Neurosci Lett. 632:218–223.
   PubMed Web of Science ®Google Scholar
• Markesbery WR. 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med. 23:134–147.
   PubMed Web of Science ®Google Scholar
• Morris R. 1984. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 11:47–60.
   PubMed Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. 2009. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 30:2785–2791.
   PubMed Web of Science ®Google Scholar
• Naliwaiko K, Araújo RL, Da Fonseca RV, Castilho JC, Andreatini R, Bellissimo MI, Oliveira BH, Martins EF, Curi R, Fernandes LC, Ferraz AC. 2004. Effects of fish oil on the central nervous system: a new potential antidepressant? Nutr Neurosci. 7:91–99.
   PubMed Web of Science ®Google Scholar
• Nampoothiri M, John J, Kumar N, Mudgal J, Nampurath GK, Chamallamudi MR. 2015. Modulatory role of simvastatin against aluminium chloride-induced behavioural and biochemical changes in rats. Behav Neurol. 2015:1.
   Web of Science ®Google Scholar
• Niehaus WG, Jr, Samuelsson B. 1968. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem. 6:126–130.
   PubMedGoogle Scholar
• Praticò D, Clark CM, Liun F, Rokach J, Lee VY-M, Trojanowski JQ. 2002. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol. 59:972–976.
   PubMedGoogle Scholar
• Prince M, Guerchet M, Prina M. 2013. The global impact of dementia 2013–2050. London, UK: Alzheimer's Disease International.
   Google Scholar
• Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I. Memantine Study Group. 2004. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA. 291:317–324.
   PubMed Web of Science ®Google Scholar
• Umar MI, Asmawi MZ, Sadikun A, Atangwho IJ, Yam MF, Altaf R, Ahmed A. 2012. Bioactivity-guided isolation of ethyl-p-methoxycinnamate, an anti-inflammatory constituent, from Kaempferia galanga L. extracts. Molecules. 17:8720–8734.
   PubMed Web of Science ®Google Scholar
• Vilar-Pereira G, Ruivo LA, Lannes-Vieira J. 2015. Behavioural alterations are independent of sickness behaviour in chronic experimental Chagas disease. Mem Inst Oswaldo Cruz. 110:1042–1050.
   PubMed Web of Science ®Google Scholar
• Vinholes J, Silva BM, Silva LR. 2015. Hydroxycinnamic acids (HCAS): Structure, biological properties and health effects.
   Google Scholar
• Weinstock M. 1999. Selectivity of cholinesterase inhibition. CNS Drugs. 12:307–323.
   Web of Science ®Google Scholar
• Wilkinson D. 2005. Pharmacotherapy of Alzheimer's disease. Psychiatry. 4:43–47.
   Google Scholar
• World Health Organization. 2012. Dementia: a public health priority. London, UK.
   Google Scholar
• Yanev PG, Dimitrova DS, Getova-Spassova DP. 2015. Effects of rivastigmine and memantine alone and in combination on learning and memory in rats with scopolamine-induced amnesia. Open Med (Wars). 10:338–345.
   Google Scholar